Nothing Special   »   [go: up one dir, main page]
Skip to main content
Springer Nature Link
Log in

The impact of M&As on company innovation: evidence from the US medical device industry

  • Published:
Scientometrics Aims and scope Submit manuscript

Abstract

The acquisition of new technologies represents a vitally important and fundamental goal of many corporate managers, particularly those within the medical device industry. We collect data on ten medical device companies as our sample in this study, covering the period from 1990 to 2006; this sample is drawn from the top 20 companies in the US, on the basis of international sales performance. We also collect details on all of the acquisitions undertaken by these companies, along with their patenting performance. The empirical results of this study suggest that technological acquisitions are only likely to be of help to the acquiring firms, in terms of improving their innovative performance, if they set out to acquire those companies that are in similar proximity, in terms of their technological field. There is also a clear need for such acquiring firms to ensure their continuing commitment to internal R&D investment in order to maintain their own versatility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. The sales revenues are ranked according to the statistics provided by MD&DI’s Industry Yearbook (2005).

  2. Examples include: Acs and Audretsch (1991), Hall and Ziedonis (2001) and Nesta and Saviotti (2004).

  3. See Hall et al. (1986) and Patel and Pavitt (1997).

  4. See for example, Griliches and Mairesse (1990) and Jang and Huang (2005).

  5. See Hall and Ziedonis (2001) and Jang and Huang (2005).

References

  • Acs, Z. J., & Audretsch, D. B. (1991). Innovation and size at the firm level. Southern Economic Journal, 57(3), 739–744.

    Article  Google Scholar 

  • Arora, A., & Gambardella, A. (1990). Complementarity and external linkages: The strategies of the large firms in biotechnology. The Journal of Industrial Economics, 38(4), 361–379.

    Article  Google Scholar 

  • Cassiman, B., Colombo, M. G., Garrone, P., & Veugelers, R. (2005). The impact of M&A on the R&D process: An empirical analysis of the role of technological- and market-relatedness. Research Policy, 34, 195–220.

    Article  Google Scholar 

  • Cloodt, M., Hagedoorn, J., & Van Kranenburg, H. (2006). Mergers and acqusitions: Their effect on the innovative performance of companies in high-tech industries. Research Policy, 35, 642–654.

    Article  Google Scholar 

  • Ernst & Young (2007). Ernst & Young’s global biotechnology report.

  • Griliches, Z., & Mairesse, J. (1990). R&D and productivity growth: Comparing Japanese and U. S. manufacturing firms. In C. Hulten (ed.), Productivity growth in Japan and the United States Vol. 53 of NBER Studies in Income and Wealth (pp. 317–348). Chicago: University of Chicago Press.

  • Hall, L., & Bagchi-Sen, S. (2007). An analysis of firm-level innovation strategies in the U.S. biotechnology industry. Technovation, 27, 4–14.

    Article  Google Scholar 

  • Hall, B. H., Griliches, Z., & Hausman, J. A. (1986). Patent and R and D: Is there a lag? International Economic Review, 27(2), 265–283.

    Article  Google Scholar 

  • Hall, B. H., & Ziedonis, R. H. (2001). The patent paradox revisited: An empirical study of patenting in the US semiconductor industry, 1979–1995. Rand Journal, 32(1), 101–128.

    Article  Google Scholar 

  • Jang, S. L., & Huang, G. G. (2005). Public R&D and industrial innovations at the project levels: An exploration of Taiwan’s public research projects. Contemporary Economic Policy, 23(4), 636–646.

    Article  Google Scholar 

  • Lerner, J., & Merges, R. P. (1998). The control of technology alliances: An empirical analysis of the biotechnology industry. The Journal of Industrial Economics, 46(2), 125–156.

    Google Scholar 

  • MD&DI’s Industry Yearbook. (2005). The Biotech Communications Group, Inc.

  • Nesta, L. & Saviotti P. (2004). Coherence of the knowledge base and firm innovative performance: Evidence from the U.S. pharmaceutical industry. SPRU Working Paper, 113.

  • Patel, P., & Pavitt, K. (1997). The technological competencies of the world’s largest firms: Complex and path-dependent, but not much variety. Research Policy, 26, 141–156.

    Article  Google Scholar 

  • Roijakkers, N., & Hagedoorn, J. (2006). Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns and networks. Research Policy, 35(3), 431–446.

    Article  Google Scholar 

Download references

Acknowledgments

The authors appreciate the financial supports from both Taiwan’s National Science Council under grant no. NSC96-2415-H-002-005-MY1 & NSC98-2815-C-002-098-H and School of Social Sciences, National Taiwan University.

Author information

Authors and Affiliations

  1. School of Medicine, National Taiwan University, Taipei, Taiwan, ROC

    Chih-Hao Lin

  2. Department of Law, College of Law, National Taiwan University, Taipei, Taiwan, ROC

    Chih-Hao Lin

  3. Department of Economics, School of Social Sciences, National Taiwan University, 21 Hsu-Chow Road, Taipei, Taiwan, ROC

    Show-Ling Jang

Authors
  1. Chih-Hao Lin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Show-Ling Jang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Show-Ling Jang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, CH., Jang, SL. The impact of M&As on company innovation: evidence from the US medical device industry. Scientometrics 84, 119–131 (2010). https://doi.org/10.1007/s11192-009-0096-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11192-009-0096-9

Keywords

Search

Navigation